BBK Worldwide Blog

BBK Worldwide

Recent Posts

PM360: Making Clinical Trials Better for Everyone in 2023

Posted by BBK Worldwide

In the January/February issue of PM360, David Fleishman joins other industry thought leaders to share their thoughts on how to make the clinical trial process more efficient, easier and accessible to a wider group of patients. 

Read More

Topics: Patient Experience, David Fleishman, PM360, Diversity, Equity and Inclusion

BBK Worldwide Launches TCN® Engage

Posted by BBK Worldwide

 

PRESS RELEASE

 

BBK Worldwide Launches TCN® Engage, a Disruptive Tech-Service Ecosystem for an Inclusive and Positive Clinical Trial Experience

Breakthrough Clinical Trial Support System Establishes a New Standard in Engagement

BBK Worldwide (BBK), the global leader in maximizing the clinical trial experience for patients and providers, today announced the launch of TCN® Engage, a breakthrough engagement ecosystem dedicated to providing a full array of visit support services from the time a patient responds to an advertisement for a clinical trial opportunity through to their completion of the study.

Read More

Topics: Technology, Most Viewed, Joan F. Bachenheimer, Rob Laurens, Press Release, TCN Engage, Concierge Support

2023: A Look into Our Crystal Ball

Posted by BBK Worldwide

 

Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.

Read More

Topics: Most Viewed, Rob Laurens, Aaron Fleishman, Elizabeth Gargill, Crystal Ball, Michael Turner, 2023 Predictions, Andre Briola, Erica Mercado

BBK Worldwide is Joining the Publicis Health Network

Posted by BBK Worldwide

 

We are very excited to kick off the new year with the announcement that we have been acquired by Publicis Health, the healthcare communications leader that transforms healthcare marketing and communications into healthcare engagement.

Read the Press Release

 

Together, we share a commitment to the clinical trial experience and to enhancing understanding and access for all, and we look forward to joining the Publicis Health network. Our mission remains unchanged, as does our commitment to supporting you in advancing your clinical R&D efforts.

 

Read More

Topics: Most Viewed, Joan F. Bachenheimer, Publicis Health, Alexandra von Plato

BBK Worldwide Launches the Engagement Solution Center

Posted by BBK Worldwide

 

BBK Worldwide Launches the Engagement Solution Center for Decentralized and Post-Marketing Clinical Trial Success

Concierge Service Delivery and Robust Patient Experience Portal Ease Clinical Trial Journey

The COVID-19 pandemic has significantly accelerated the need to reshape research and development. Most specifically, it has led to demand for increased funding for decentralized and larger randomized clinical trials to inform clinical decisions and guide future research.

By launching the Engagement Solution Center, BBK Worldwide (BBK) is making patient-centric and inclusive trials an immediate and actionable reality for study sponsors.

Read More

Topics: TrialCentralNet, Rob Laurens, Decentralized Trials, Engagement Solution Center, Patient Centric, Post-Marketing

3 Decentralized Clinical Trial Solutions Trending Now

Posted by BBK Worldwide

 

 

3 Decentralized Clinical Trial Solutions Trending Now

 

Ever wonder which products and services study sponsors are leveraging for enrollment and engagement success? We thought we would take a moment to share the products and services gaining traction with our clients who are embracing decentralized clinical trials. And while it's always important to keep in mind that each study protocol is unique and requires its own analysis to determine the right solutions, we're sharing three popular ones below.

Read More

Topics: Patient Reimbursement, Decentralized Trials, Medication Delivery, In-home Nurse Visits, Mobile Wallet

Global Strategist Amanda Moody on BBK's Commitment to Parkinson’s Disease Research

Posted by BBK Worldwide

 

We recently sat down with BBK’s Global Strategist Amanda Moody to discuss the company’s commitment to Parkinson’s disease clinical research, including ongoing innovation designed to foster a positive and meaningful patient journey. 

Can you briefly describe BBK’s experience with the Parkinson’s disease community?

We have a long-standing commitment to the Parkinson’s community, both in terms of supporting clinical research as well as individual patient and caregiver needs. 

Read More

Topics: RSG Arrive, RSG Card, Parkinson's disease, The Michael J. Fox Foundation, Amanda Moody, Parkinson's Disease Therapeutics Webinars